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1999; Milner and Bigas, 1999). In general, Notch activa-Barbara Osborne*³ and Lucio Miele²
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stimulus rather than directly specifying a cell fate. SinceUniversity of Massachusetts
Notch ligands are predominantly cell membrane associ-Amherst, Massachusetts 01003
ated, Notch signaling is thought to mediate interactions²Cancer Immunology Program
between contiguous cells. However, a soluble form ofCardinal Bernardin Cancer Center
the Drosophila Notch ligand Delta recently has beenLoyola University Medical Center
identified, suggesting that, in some contexts, Notch mayMaywood, Illinois 60153
also mediate interactions between noncontiguous cells
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Experiments employing targeted disruption or ectopicNotch proteins are a family of evolutionarily conserved
elevated expression/activity of Notch and Notch ligandstransmembrane receptors that regulate cell fate deci-
have provided insights into the processes controlled orsions during development and postnatal life in organ-
influenced by Notch signaling. Interestingly, an impor-isms as diverse as worms, flies, and humans. This family
tant conclusion of these studies is that Notch receptorsof receptors plays a variety of critical roles in the devel-
and ligands are, for the most part, essential for embry-opment of these species. Strong experimental evidence
onic development. In mice, targeted disruption of theindicates that Notch receptors have multiple, crucial
genes NOTCH-1 or NOTCH-2 or the Notch ligand genesregulatory functions in T cell development and hemato-
JAGGED-1 or JAGGED-2 results in embryonal lethalitypoiesis. The tissue distribution of Notch expression sug-
or severe developmental defects (Swiatek et al., 1994;gests that this receptor family may also play a role in
Conlon et al., 1995; Jiang et al., 1998; Hamada et al.,regulating the function of peripheral lymphoid cells and,
1999; Xue et al., 1999). The intracellular domain of Notchthus, affect immune responses. In this review, we sug-
mimics a constitutively active form of the protein. Whengest that Notch both specifies cell fate in the hematopoi-
this truncated intracellular domain is expressed in imma-etic lineage and regulates cell death decisions, and we
ture myoblasts or granulocytic cells lines, terminal differ-speculate upon the mechanisms by which Notch exerts
entiation is inhibited (Kopan et al., 1994; Milner et al.,these pleiotropic effects in the immune system.
1996). Normal Notch activation occurs through binding
with a ligand, and ligand-induced activation of Notch-1
Notch Receptors and Ligands is demonstrated to inhibit CD341 hematopoietic precur-
There are four vertebrate NOTCH genes (NOTCH-1, sor maturation (Li et al., 1998) and oligodendrocyte mat-
-2, -3, and -4) and these are highly related to each other uration (Wang et al., 1998). Overall, these data suggest
and to the Drosophila notch and C. elegans lin-12 and that, in many contexts, Notch activation inhibits or de-
glp-1 genes (Lardelli et al., 1995). There also are multiple lays differentiation toward a specific fate and thus en-
Notch ligands in vertebrates and these are homologous ables a cell to respond to stimuli that induce an alternate
to the Drosophila ligands Delta and Serrate and the C. fate. However, in some experimental models, such as
elegans ligand Lag-2 (reviewed in Weinmaster, 1997). CD4 versus CD8 and ab versus gd lineage decisions in
In mammals, Delta homologs are called ªDelta-likeº and thymocytes (Robey et al., 1996; Washburn et al., 1997),
the Serrate homologs are called ªJaggedº (see Table 1). Notch signaling seems to be required for correct pro-
Notch receptors and ligands contain multiple EGF-like cessing of differentiation stimuli.
repeats in their extracellular domains. Notch ligands
also contain a characteristic, cysteine-rich N-terminal Notch Signaling
domain (the DSL domain), which appears to be responsi- Complexity and context dependence characterize Notch
ble for Notch binding. signaling (Artavanis-Tsakonas et al., 1999). Complexity
results from several factors: (1) multiple Notch receptors
and ligands exist, with partially overlapping organ distri-Functions of Notch Receptors
butions and functions; (2) multiple signaling pathwaysNotch receptors mediate three different processes (Ar-
can be triggered by Notch activation; (3) Notch signalingtavanis-Tsakonas et al., 1999): (1) lateral specification/
can be modulated by numerous intra- and extracellularinhibition, in which identical, equipotent cells restrict
proteins acting through different mechanisms; (4) Notchand coordinate each other's developmental fates; (2)
receptor processing is intertwined with signaling; andinductive signaling, in which one cell type regulates an-
(5) the level of expression of Notch receptors influencesother cell type's differentiation choices; and (3) cell-
the effects of Notch signaling. These factors help explainautonomous effects, in which a cell regulates it own fate
the context dependence of Notch effects. For clarity,through Notch signaling. A comprehensive overview of
we shall describe separately Notch receptor processing,Notch functions and signaling is beyond the scope of
including ligand-dependent processing; downstream
this article, and the reader is referred to several recent
mediators of Notch signaling; and downstream targets.
reviews (Greenwald, 1998; Artavanis-Tsakonas et al.,
Ligand-Dependent and -Independent Steps
in Notch Receptor Processing
The processing of Notch proteins is very complex and³ To whom correspondence should be addressed (e-mail: osborne@
vasci.umass.edu). rather unusual. Initially, Notch proteins are synthesized
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a proteolytic cleavage within or near the membrane andTable 1. Notch and Notch Ligands
this is known to require presenilin-1 (Figure 1C) (De et
Organism Notch Receptors Ligands* al., 1999; Song et al., 1999; Struhl and Greenwald, 1999;
Ye et al., 1999). Presenilins are multiple-pass transmem-Drosophila Notch Delta
Serrate brane proteins that are mutant in most cases of familial,
C. elegans Lin-12 Lag-2 early onset Alzheimer's disease (reviewed in Cruts and
Glp-1 Apx-1 Van Broeckhoven, 1998). The precise role of presenilin-1
Vertebrates Notch-1 Jagged-1
in Notch processing remains to be established. It isNotch-2 Jagged-2
still unclear whether ligand binding initiates proteolyticNotch-3 Dll 1 (Delta-like 1)
cleavage of NIC from the rest of the receptor or simplyNotch-4 Dll 3 (Delta-like 3)
induces the dissociation of a precleaved NIC.
* It is still unclear to what extent different ligands function to activate
Downstream Mediatorsspecific receptors under physiological conditions.
The transcriptional regulator Suppressor of Hairless
[Su(H)] is the primary mediator of Drosophila Notch (For-
tini and Artavanis-Tsakonas, 1994). Su(H) and its mam-
as single polypeptide precursors, which are proteolyti- malian homolog CBF-1 binds NIC, the active form of
cally processed to a heterodimeric, mature form (Figure intracellular Notch, resulting in activation of transcrip-
1) (reviewed in Artavanis-Tsakonas et al., 1999). During tion. The cleaved NIC interacts with Su(H)/CBF-1 primar-
maturation, Notch precursors (Figure 1A) are cleaved ily through a defined sequence N-terminal to the ankyrin
into an extracellular subunit (NEC) containing multiple repeats (known as RAM23) (Tamura et al., 1995). CBF-1
EGF-like repeats and a transmembrane subunit (NTM) is ubiquitously expressed in most mammalian cells, and
containing a short extracellular tail in addition to the in the absence of activated Notch, it functions as a
intracellular domain (NIC) (Blaumueller et al., 1997) (Fig- transcriptional repressor (Hsieh and Hayward, 1995; Os-
ure 1B). These subunits are reassembled into a hetero- wald et al., 1998). Recent data indicate that CBF-1 re-
dimeric, mature receptor. Interaction with ligands trig- pressor activity may be mediated by a complex includ-
gers the release of the NIC of the Notch protein (Figure ing CBF-1, a nuclear hormone corepressor, and histone
1C). This intracellular form of Notch is the portion of the deacetylase 1 (HDAC-1) (Kao et al., 1998). Nuclear hor-
molecule that mediates signaling. NIC contain a series mone corepressors that associate with CBF-1 include
of ankyrin repeats similar to those found in IkB and NF- SMRT (Kao et al., 1998), N-CoR (Kao et al., 1998), and
kB. Ankyrin repeats are thought to be critical in mediat- a novel CBF-1-specific corepressor called CIR (Hsieh
ing the binding of many of the intracellular proteins et al., 1999). Notch binding appears to dissociate the
known to interact with Notch. Two putative nuclear lo- corepressor and HDAC-1 from CBF-1, converting CBF-1
calization sequences are also present within NIC, along into a transcriptional activator. This, in turn, results in
with other structural motifs that may be functionally im- the expression of Notch target genes.
Not all signals from Notch receptors are mediated byportant (Figure 1). Ligand-induced release of NIC requires
Figure 1. Structure and Processing of a
Notch Receptor
Diagrams represent Notch proteins with the
N terminus on the left.
(A) Notch receptors are synthesized as single
polypeptide precursors.
(B) During maturation, a furin-like convertase
cleaves the extracellular subunit NEC from the
transmembrane subunit NTM. These two sub-
units are reassembled as a heterodimer in
the trans-Golgi. It is unclear whether the NEC
subunit is further processed by an ADAM-
family protease.
(C) A second cleavage, which requires pre-
senilin-1, cleaves the NTM subunit within or
immediately distal to the plasma membrane,
generating the intracellular subunit NIC and
a short transmembrane fragment. The latter
cleavage appears to be necessary for Notch
signaling. It is still unclear whether this cleav-
age is induced upon ligand binding or hap-
pens during receptor maturation. Abbrevia-
tions: LP, leader peptide; EGF, EGF-repeat
region; 11±12, EGF repeats 11 and 12, which
are the main ligand binding site in Drosophila;
L/N, Lin/Notch cysteine-rich repeats; TM, sin-
gle pass transmembrane region; RAM23, high
affinity CSL-binding site; ANK, ankyrin/CDC10-
like; OPA, glutamine-rich region; PEST, pro-
line-glutamate-serine-threonine-rich region (this
region presumably regulates protein stability).
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Figure 2. Notch Signaling Pathways
(A) Schematic representation of the current
working hypotheses for CBF-1/Su(H)-medi-
ated and Deltex-mediated Notch signaling.
Abbreviations: CBF-1/Su(H), CBF-1/Suppres-
sor of Hairless/transcriptional regulators; E(Sp),
Notch target genes of the Enhancer of Split
group; HES, Hairy/Enhancer of Split [bHLH
mammalian homologs of Drosophila E(sp)];
JNK, c-Jun N-terminal kinase; E47, bHLH
transcription factor E47.
(B) Putative mediators of Notch activity. In
addition to CBF-1/Su(H) transcriptional regu-
lators and Deltex, direct binding of several
other key signaling molecules to Notch has
been described. These include the chroma-
tin-remodeling factor EMB-5 in C. elegans,
the p50 subunit of NF-kB in human T cell
lines, the c-Abl accessory protein Disabled
(Dab) in neurons, and the orphan nuclear re-
ceptor Nur77 in mouse T cell hybridomas.
CBF-1. A CBF-1-independent pathway has been de- may have significant effects on cell death of lymphoid
cells. The Deltex-mediated inhibition of E47 is also ofscribed (Figure 2A) that involves the intracellular Notch-
binding protein Deltex (Ordentlich et al., 1998; Zecchini potential immunological relevance, since E47 and its
close relatives E12 and HEB are critical regulators ofet al., 1999). Deltex is a conserved, zinc finger cyto-
plasmic protein, which binds to the intracellular domain both B and T cell development (reviewed in Bain and
Murre, 1998); this is discussed in detail below.of Notch and does not appear to migrate to the nucleus
upon Notch activation (Matsuno et al., 1998). Signals Many other Notch signaling pathways, too numerous
to describe, have been suggested in recent monthsthrough the Notch/Deltex pathway can result in repres-
sion of the basic helix-loop-helix (bHLH) protein E47 (summarized in Figure 2B) (reviewed in Artavanis-Tsako-
nas et al., 1999; Miele and Osborne, 1999; Milner andthrough a mechanism involving Ras and c-Jun N-termi-
nal kinase (JNK) (Ordentlich et al., 1998). In particular, Bigas, 1999). Additionally, many proteins that can modu-
late Notch activity have been described. Whether or notactivation of Notch leads to activation of Deltex, which
in turn binds to Grb2 (Matsuno et al., 1998). This is this host of proteins is important in modulating Notch
activity in lymphoid cells remains to be determined. Ad-thought to lead to repression of JNK-mediated activa-
tion of E47. ditionally, it is not yet clear whether all Notch receptors
use a ªcommonº signaling pathway or whether there areDownstream Targets
Many Notch target genes have been identified but for ªprivateº pathways specific for individual Notch family
members. Very recent evidence indicates that Notch-1the immune system, perhaps one of the most important
targets of Notch signaling is a family of bHLH proteins and -3 may have antagonistic effects under some cir-
cumstances (Apelqvist et al., 1999; Beatus et al., 1999).known as HES (Hairy-Enhancer of Split). In particular,
HES-1 is expressed in the immune system, and targeted This in turn suggests that individual Notch receptors
may indeed utilize different signaling pathways and, ad-disruption of the HES-1 gene has severe consequences
on the immune system. As detailed below, these conse- ditionally, cross-talk with one another.
The emerging picture of Notch signaling is that of aquences include defects in thymic development. An-
other immunologically interesting target of Notch is finely tuned cascade of transcriptional regulatory events
that affects multiple cellular functions simultaneously.NF-kB2 (p100/p52). Recent data (Oswald et al., 1998) sug-
gest that CBF-1 normally represses NF-kB2 expression This signaling network may be modulated by many vari-
ables. These may include the level and time course ofin the absence of Notch signaling. Active Notch-1 con-
verts CBF-1 into a transcriptional activator and in- expression, the subcellular localization and posttransla-
tional modification of Notch proteins, and other networkcreases the expression of NF-kB2 (p100/p52). Since NF-
kB activity has been associated with protection from components. The overall signal transmitted by this com-
plex network can affect all three major branches of theapoptosis in lymphoid tissue (see below), it is possible
that the release of repression through Notch signaling cell fate ªdecision treeº: differentiation, proliferation,
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and programmed cell death (for reviews see Artavanis- CD81 SP thymocytes. The data suggested to the authors
that NIC expression influences the choice between CD4Tsakonas et al., 1999; Miele and Osborne, 1999). In the
and CD8 T cell lineages. A caveat to these observationscontext of the immune system, we provide specific ex-
was that the CD8 cells, while present in higher numbersamples of how Notch signals influence each of these
than normal, were short-lived and could not be foundthree branches and further suggest that some effects
in peripheral lymphoid tissues. Therefore, in this veryupon cell fate may well be regulated through Notch
interesting first link between the immune system andeffects on cell survival.
Notch, we find that activated Notch can regulate the
differentiation of thymocytes into either CD4 or CD8 SPNotch Effects on the Immune System
cells.There is a substantial body of literature detailing the
Another series of experiments conducted with miceexpression of Notch family members as well as Notch
heterozygous for Notch expression provided evidenceligands in cells and tissues of the immune system,
that Notch-1 NIC also can effect the decision betweenand these reports provide supportive evidence that en-
ab and gd TCR lineages (Washburn et al., 1997). Nor-dogenous Notch expression mediates immune function.
mally, mice express larger numbers of ab T cells thanNotch-1 and Notch-2 are expressed in human (Milner et
gd T cells. The data from these experiments suggestedal., 1994) and mouse (Varnum-Finney et al., 1998) CD341
that a reduction in Notch expression (N11/2) leads tohematopoietic precursors. Jagged-1 is expressed on
the accumulation of gd T cells. Reciprocal experimentsbone marrow stromal cells (Li et al., 1998). Notch expres-
where the transgenic NIC mice were used supportedsion also is observed in the thymus. Earlier data sug-
this observation. These data suggest a second effectgested immature outer cortical CD42CD82 (DN) thymo-
of Notch signaling on thymic differentiation, separatecytes express high levels of Notch-1, while CD41CD81
from that on CD4/CD8 lineage differentiation.(DP) thymocytes express little to no Notch-1, and the
More recent and compelling evidence supports a rolemost mature CD41 or CD81 (SP) thymocytes express
of Notch-1 in the expansion of early thymocyte precur-an intermediate level of Notch-1 (Hasserjian et al., 1996).
sors and in the lineage choice between B and T cell fates.More recent data suggests that the patterns of expres-
Transgenic mice have been described with induciblesion described previously may be somewhat simplistic.
inactivation of the NOTCH-1 gene obtained using theIn fact, it appears that Notch-1, -2, and -3 are all ex-
cre/lox targeted recombination system (Radtke et al.,pressed in the thymus in variable fractions of all thymo-
1999). In this study, mice with a NOTCH-1 deletion incyte subpopulations (Felli et al., 1999). Additionally, Jag-
the bone marrow and thymus displayed severe deficien-ged-1 and Jagged-2 are both expressed in thymic
cies in thymic development at the CD441CD252CD32stromal cells and Jagged-2 also is expressed in thymo-
DN stage (Radtke et al., 1999). Interestingly, B220 cellscytes. Taken together, it appears that the potential for
develop in the thymus of these mice. This may suggestdifferent Notch family members to interact with at least
that early lymphoid precursors, in the absence oftwo different ligands exists and, hence, it may be likely
Notch-1 signaling, choose a B cell fate in a bone mar-that signals from one Notch family member may regulate
row±independent fashion. This hypothesis is strongly
one process, while signals from another family member
supported by a very recent observation (Pui et al., 1999).
will regulate another event. The physiological relevance
These authors have shown that retroviral transduction
of Notch receptors and ligands in the immune system
of constitutively active Notch-1, NIC, into murine bone
is supported by strong functional evidence. The data marrow precursors results in the development of imma-
discussed below suggest that these proteins do exert ture, DP T cells in the bone marrow (which eventually
significant and, almost certainly, pleiotropic effects on tend to give rise to T cell lymphomas) and completely
lymphoid development. We shall separately discuss ef- prevents B220 cell development.
fects of Notch signaling on differentiation, proliferation, How does Notch influence differentiation in lymphoid
and death in the immune system. Evidence supporting cells? One plausible interpretation of the data described
the role of specific Notch ligands in immune system above comes from studies that link HES-1 to CD4 ex-
development will be presented as well. pression (Kim and Siu, 1998). In these experiments,
Notch as an Effector of Differentiation HES-1, a bHLH transcription factor induced by Notch/
The first clue for a role of Notch in lymphoid development CBF-1 activation, was shown to bind to a site in the
came from experiments conducted with mice carrying CD4 silencer and overexpression of HES-1 was found to
a Notch-1 transgene. The transgene used in these ex- repress CD4 expression through binding to the silencer.
periments is a truncated form of intracellular Notch-1 Additionally, NIC could mimic the effects of HES-1 on
driven by the lck proximal promoter ensuring expression CD4 expression. Taken together, the data strongly sup-
in double-positive (DP) thymocytes (Robey et al., 1996). port the hypothesis that Notch signaling can repress
The truncation results in a removal of the C-terminal CD4 expression. Interestingly, although HES-1 overex-
region of the NIC of the Notch-1 protein, a region con- pression can repress CD4 expression in an SP T cell
taining sequences reported to regulate rates of Notch line, overexpression of HES-1 in transgenic mice does
protein turnover, so a cautionary note is that the protein not lead to increased development of CD8 SP T cells.
encoded by this transgene may have altered rates of These data suggest that HES-1 can repress CD4 but
Notch turnover. These transgenic animals have interest- HES-1 is not sufficient to alter CD4/CD8 ratios in vivo.
ing alterations in thymic development. Whereas normal It may be that Notch/Deltex-mediated signals or Notch/
mice have approximately 2- to 3-fold more CD41 than CBF-1 effectors other than HES-1 are needed for com-
CD81 single-positive (SP) thymocytes, activated Notch plete silencing of CD4. Whether Notch-1 directly upregu-
lates CD8 expression has not been established yet, nor(NIC) mice have as many as 10-fold higher numbers of
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is it clear whether the actual choice between CD4 and (2B4.11). Glucocorticoid receptor levels or known down-
stream effector genes were not affected. The RAM23CD8 fates or the subsequent development/survival of
region, the region where CBF-1 binds, was shown to beCD8 cells are Notch-1 dependent.
necessary for this effect, suggesting that it is CBF-1HES-1 also affects early thymocyte precursors, as
dependent. However, Deltex expression was upregu-evidenced by a recent report where HES-1 null mice
lated by constitutively active Notch-1, suggesting thatwere found to have a block in T cell development (Tomita
Deltex-mediated events may also participate in this ef-et al., 1999). HES-12/2 mice do not survive past birth,
fect. Finally, thymocytes from transgenic mice express-but it is possible to analyze the developing embryonic
ing a truncated, constitutively active Notch-1 under thethymus in these mice. Such analyses show that the most
lck promoter showed relative resistance to dexa-of the HES-12/2 mice completely lack a thymus, and
methasone-induced apoptosis. These data indicate thatthose few that retain a thymus have a significantly
Notch-1 signaling has complex effects on moleculessmaller thymus. Examination of chimeras in which HES-1
involved in T cell development and that activation ofnull fetal liver was injected into irradiated RAG2 null mice
Notch-1 may protect thymocytes from death by neglectrevealed that B cells developed normally while T cell
mediated by glucocorticoids.development was arrested at the DN stage of thymic
In the second report, the authors (Jehn et al., 1999)development. The results from these experiments led
show that in a T cell hybridoma (DO11.10), constitutivelythe authors to conclude that in the absence of HES-1,
activated forms of Notch-1 inhibit Nur-77-dependentT cell development arrests at the CD441CD252CD32 DN
apoptosis. Nur-77 is a nuclear hormone receptor, andstage of thymic development, and the HES-1 mutation
Nur-77 and its close relative, Nor1, are upregulatedseverely affects the expansion of immature T cells be-
during apoptosis induced by T cell receptor (TCR) en-fore TCR gene rearrangement. Remarkably, this pheno-
gagement and are required for TCR-mediated apoptosistype is very similar to the one produced by conditional
during negative selection (Liu et al., 1994; Winoto, 1997).inactivation of the NOTCH-1 gene (Radtke et al., 1999).
The authors identified the intracellular region of Notch-1Another group of Notch targets that are important in
as a candidate Nur-77-binding protein in yeast two-hybridimmune system development are the bHLH transcription
experiments and confirmed the interaction in affinityfactors collectively known as E proteins (for review see
capture experiments (Jehn et al., 1999). Additionally,Bain and Murre, 1998). There are four mammalian E
this group, using luciferase reporter constructs, demon-proteins, E12, E47, E2-2, and HEB, and all can bind to
strated that Notch-1 expression results in the repressionsites in DNA called E boxes as either homodimers or
of Nur77-induced transcription. Taken together, dataheterodimers with tissue-specific bHLH proteins. Data
from both groups suggest that Notch signaling may reg-from several laboratories have shown that the E2A gene,
ulate apoptosis during thymocyte maturation by pre-which encodes both proteins E47 and E12, plays an
venting death by neglect and/or negative selection inintimate role in lymphoid development (Bain and Murre,
cells destined to die.1998). E boxes are found in immunoglobulin enhancers,
As detailed above, Notch signaling has been impli-TCR enhancers, and in the CD4 silencer and enhancer
cated in CD4 versus CD8 decisions (Robey et al., 1996),elements (reviewed in Bain and Murre, 1998). Therefore,
and these results were interpreted to demonstrate a roleE proteins have the potential to regulate the activity of
for Notch-1 in regulating the choice between the CD4genes essential for the normal development of both T
versus the CD lineage. The results described aboveand B cell lineages. As described above, Notch-1 signal-
(Deftos et al., 1998; Jehn et al., 1999) establishing thating through Deltex results in repression of E47 activity.
Notch-1 renders T cells resistant to apoptosis provideAn inhibitory effect of Notch-1 NIC on E2A-dependent
an alternate interpretation of the role of Notch-1 in thy-transcription was confirmed by Pui et al. (1999). A partic-
mocyte maturation. If Notch-1 is capable of rescuing Tularly attractive hypothesis is that Notch-1, through Del-
cells from apoptosis, then it is likely that Notch-1 may
tex, might regulate E47 (and/or E12) activity, and this
enhance the survival of CD8 lineage cells, thus resulting
might contribute its effects on B versus T cell fate deter-
in an accumulation and enhanced numbers of CD81 SP
mination, as well as to an alteration of TCR ab versus thymocytes. This interpretation is supported by obser-
gd ratios and CD4 expression patterns. It is entirely vations of others showing that ectopic Bcl-2 expression
possible that the studies discussed above on transgenic in the developing thymus results in the development of
overexpression of Notch-1 NIC and conditional NOTCH-1 CD81 SP thymocytes (Sentman et al., 1991; Strasser et
knockout can be explained in large part by the effects al., 1991). In light of these data, we suggest that at
of Notch-1 on HES-1 expression in addition to the effects least one role of Notch in lymphoid development is the
of Notch-1 on E47/E12. provision of an antiapoptotic signal, which in turn results
Notch as an Effector of Cell Death in the rescue of a cell normally destined to die. It is
In addition to cell fate effects on T cell lineages, Notch entirely possible that Notch signaling in the thymus may
recently has been reported to affect cell death. Two regulate both differentiation programs and apoptosis.
groups have independently discovered that Notch-1 has The expression pattern of Notch-1 in the thymus (see
antiapoptotic properties in T cell systems. The observa- above) may support such a model. Whether this hap-
tions reported suggest that Notch-1 may regulate ªdeath pens predominantly in those thymocytes whose cell
by neglectº and/or negative selection. In one study, the phenotype is thought to be induced by increased Notch
authors (Deftos et al., 1998) reported that retrovirally signaling, i.e., gd TCR (Washburn et al., 1997) and CD8
transduced, constitutively active Notch-1 inhibits gluco- cells (Robey et al., 1996), remains to be established. In
corticoid-induced cell cycle arrest and apoptosis in a human peripheral blood T cells, expression of Notch-1
mRNA and protein can be detected in both CD4 andthymic lymphoma line (AKR1010) and a T cell hybridoma
Immunity
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Figure 3. Putative Functions of Notch-1 Sig-
naling during Thymocyte Development
Black arrows indicate developmental pro-
cesses. Blue arrows indicate effects of
Notch-1 that stimulate (pointed arrowheads)
or inhibit (flat arrowheads) a given develop-
mental process. Cell fate decisions affected
by Notch-1 are enclosed in boxes. Experi-
mental evidence from several groups sug-
gests that Notch-1 may be involved in several
steps during thymocyte development, namely,
(1) the choice of early common lymphoid pre-
cursors between B and T cell lineage devel-
opment, (2) the expansion of early CD441
CD252 lymphocyte precursors, (3) the matu-
ration of ab TCR cells, (4) the development
of CD81 cells from DP cells, (5) inhibition of
glucocorticoid-induced apoptosis (death by
neglect), and (6) inhibition of TCR-induced
apoptosis (negative selection). Recent data
show that Notch-2 and -3 are also expressed
in the thymus. Their respective roles in thy-
mocyte development are still unclear.
CD8 SP cells (L. Shelly and L. M., unpublished data). that Notch-1 prevents apoptosis in MEL cells and that
the rapid increase in Notch-1 expression induced byThis raises the separate and speculative question of
whether Notch signaling has a role in regulating apo- differentiation signals is necessary to maintain survival
in precommitted cells.ptosis during the immune response, for example, during
the establishment of immunological memory. The puta- Notch as an Effector of Proliferation
As discussed above, in much the same manner thattive functions of Notch signaling during thymocyte de-
velopment supported by experimental evidence are Notch/Delta interaction regulates the maintenance of
neuronal precursors in flies, Notch/Jagged interactionssummarized in Figure 3.
Another piece of evidence implicating Notch as an may well contribute to the maintenance of primitive he-
matopoietic precursors in humans and mice. In additionantiapoptotic protein in myeloid lineage cells comes
from data obtained in murine erythroleukemia (MEL) to this role of maintenance of precursor pools, Notch-1
has been shown to effect cell cycle kinetics in humancells. In this study, the authors (Shelly et al., 1999) in-
vestigated whether Notch signaling participates in dif- hematopoietic cells (Carlesso et al., 1999). In these ex-
periments, Notch-1 activation delayed differentiation offerentiation induced by hexamethylene-bisacetamide
(HMBA). Like many other tumor lines, MEL cells express both HL-60 cells as well as primary CD341 progenitor
cells and this delay correlates with a shortening of thereadily detectable amounts of Notch-1 protein. When
these authors induced differentiation in MEL cells, G1 phase of the cell cycle, suggesting that the inhibition
of differentiation might possibly be the result of alteringNotch-1 was rapidly and transiently upregulated and
disappeared with commitment to terminal differentia- cell cycle kinetics (Carlesso et al., 1999). This function
of Notch-1 may be important in ensuring the expansiontion. When the upsurge in Notch-1 expression was
blunted with three different Notch-1 antisense S-oligo- of bone marrow precursors and possibly of early thymo-
cyte precursors. Under different conditions, i.e., in thenucleotides, MEL cell differentiation was inhibited and
apoptosis was induced (Shelly et al., 1999). MEL clones absence of growth-promoting cytokines, Notch activa-
tion by cells expressing Jagged-1 appeared to inhibitstably transfected with an 1100 bp antisense notch-1
construct showed drastically inhibited differentiation proliferation of human CD341 cells (Walker et al., 1999).
This suggests that Notch signaling can modulate growthand a striking loss of viability due to apoptosis upon
HMBA treatment, compared to clones transfected with signals in bone marrow precursors and that the effects
of Notch activation most likely depend upon cellularempty vector (Shelly et al., 1999). These data suggest
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context (i.e., presence or absence of growth stimulatory downstream responses? Almost certainly the latter is
true. In fact, Notch signaling is better visualized as asignals).
complex and multifaceted network than as a simpleThe Role of Notch Ligands
linear pathway (Artavanis-Tsakonas et al., 1999). It isThe functional outcome of Jagged-2 expression in the
well documented that Notch can signal via CBF-1 orthymus is suggested by data obtained from the targeted
independent of CBF-1, and experiments describeddeletion of the portion of the Jagged-2 protein required
above provide evidence that both signaling pathwaysfor Notch interaction (Jiang et al., 1998). Mice carrying
are important in the immune system (summarized inthis mutation die perinatally due to a number of develop-
Figure 4).mental defects including cranofacial abnormalities that
CBF-1 mediated Notch signals include the role ofresult in the fusion of the tongue to the palate, causing
HES-1 in T cell development. As described above, HES-1the mice to suffocate shortly after birth. Removal of pups
can repress CD4 expression through its interaction withat E18 (18th day of gestation) allows a determination of
the CD4 silencer (Kim and Siu, 1998) and HES-1 also isthe effect of mutations in Jagged-2 on thymic develop-
critical for the expansion of early T cell precursors (To-ment. E18 Jagged-2 homozygous mutant pups display
mita et al., 1999). This suggests that HES-1 is importantimpaired differentiation of the gd lineage of thymocytes
at least at two temporal points during thymic develop-and reduced complexity of the medullary regions of the
ment, in early DN cells, and later in DP cells. Finally,thymus, indicating that Jagged-2/Notch interaction is
CBF-1 also can upregulate the expression of NF-kB2required for morphological development of the thymus
and NF-kB can block cell death in many cell types,as well as development of the gd lineage (Jiang et al.,
including T cells (Ferreira et al., 1999; Kolenko et al.,1998). These data are in contrast to the effects found
1999) and CD341 hematopoietic precursors (Pyatt et al.,by overexpression of Notch-1 NIC (Washburn et al.,
1999).1997), but it may be difficult to compare data from null
CBF-1-independent signals are best highlighted bymutations of a ligand (Jagged-2) to data obtained from
Deltex-regulated events. While there is little evidenceoverexpression of constitutively activated Notch. In an-
that Deltex regulates immune development, genesother study, Jagged-2 expression was assessed directly
downstream of Deltex have been implicated as impor-and found to be expressed at E14 in the cortical region
tant regulators of the immune system. In particular, itof the thymus (Luo et al., 1997), suggesting that although
is well documented that E proteins such as E2A (E2Amutations in Jagged-2 result in defects in the architec-
encodes E47 and E12) and HEB play a profound role inture of the thymic medulla, this may be through impair-
both B and T cell development. For example, E47 dimersment of Jagged-2 expression in cortical regions of the
favor B cell lineage commitment, while E47/HEB dimersthymus.
influence T cell development (for review see Bain andJagged-1 also is known to be expressed in the adult
Murre, 1998). These conclusions are supported by stud-human thymus, B cells, and marginal zones of germinal
ies in E2A null animals. In E2A null animals, B cell devel-centers (Bash et al., 1999). A potentially important obser-
opment is completely blocked at the earliest identifiablevation for our understanding of Notch regulation of im-
stage (Bain et al., 1994). T cell maturation also is affectedmune function is the recent report that Rel/NF-kB can
in these animals (Bain et al., 1997). There is a severeinduce the expression of the Notch ligand, Jagged-1
reduction in the number of DP thymocytes found in these(Bash et al., 1999). In an attempt to determine the down-
animals. Additionally, the animals develop T cell lympho-stream effects of c-Rel expression, the authors found
mas at an early age that express both CD4 and CD8.by differential display that c-Rel expression results in
Interestingly, when lymphomas from E2A null animalsexpression of Jagged-1 and that Jagged-1 expression
are reconstituted with either E47 or E12 via transfection,is dependent upon endogenous NF-kB activation. Fur-
the cells undergo a rapid apoptotic death, suggestingthermore, the authors demonstrated that c-Rel can in-
that overexpression of E2A gene products can induce
duce Notch signaling, presumably through the induction
a death signal (Engel and Murre, 1999).
of Jagged-1, which in turn binds and activates Notch
Until recently, there was no direct evidence that Notch
(Bash et al., 1999). There is a large body of literature directly regulated E protein expression or function in
demonstrating activation of NF-kB in many cells and the immune system, but enforced expression of consti-
tissues of the immune system, and the data described tutively active Notch-1 in bone marrow precursors,
above suggest that one effect of NF-kB activation may which could result in maximal E47 inhibition, also causes
be activation of Notch signaling. DP T cell lymphomas (Pear et al., 1996), mimicking a
phenotype observed in the E2A null animals. A conclu-
How Does Notch Signaling Exert Pleiotropic sive link between Notch and E47 is provided in a recent
Effects on the Immune System? paper where Notch-1 activity expressed in hematopoi-
In previous paragraphs, we described numerous effects etic precursors drive T cell development and completely
of Notch signaling on the immune system. It is clear that block B cell development (Pui et al., 1999). In these
Notch and Notch ligand expression are observed in most experiments Notch-1 expression is shown to block acti-
cells and tissues of the immune system, including the vation of the E2A-regulated promoter, suggesting that
early hematopoietic precursors. It also is clear that enforced Notch-1 expression in these cells blocks E2A.
Notch signaling can result in numerous functional ef- Indeed the phenotype of the E2A2/2 mice is very similar
fects on differentiation, death, and proliferation of cells to the phenotype of mice derived by overexpression of
in the immune system. How does this one signaling activated Notch-1 in bone marrow precursors (Pui et al.,
pathway mediate such pleiotropic effects? Do all Notch 1999).
These observations may provide insight into some ofsignals converge or does Notch signaling initiate many
Immunity
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Figure 4. Hypothesis of the Possible Mechanisms of Notch Pleiotropic Effects during T Cell Development
Through CBF-1 mediated induction of HES-1, Notch may stimulate the expansion of CD441CD252 precursors and subsequently silence CD4
expression in cells destined for the CD81 lineage. Whether HES-1 directly stimulates CD8 expression is still unclear. Through CBF-1-mediated
induction of p100/NF-kB2, Notch can increase resistence to apoptosis and thus inhibit cell death. Through Deltex-mediated inhibition of E47
homodimers, Notch could block B cell fate commitment (which requires E47) and subsequently cell death or CD4 expression induced by
JNK-activated E47 homodimers. Inhibition of E47 homodimers may favor the formation or the activity of E47/HEB heterodimers, which are
necessary for T cell lineage commitment of early precursors.
the numerous effects that Notch signaling has on the have shown that Notch expression rescues cells from
apoptosis (Deftos et al., 1998; Jehn et al., 1999; Shellyimmune system. As shown pictorially in Figure 4, Notch
signaling through CBF-1 and HES-1 can affect early et al., 1999). If Notch can block cell death, it is quite
possible that fate determination and cell survival may bethymocyte expansion and regulate CD4 versus CD8
ratios. Through CBF-1-induced NF-kB2 expression, functionally equated. Take, for example, the observation
that activated Notch expression drives T cell lineageNotch-1 may provide an antiapoptotic signal. Through
Deltex-mediated repression of E47, Notch also can reg- commitment (Pui et al., 1999). If we assume the precur-
sors destined to become T cells are susceptible toulate CD4 versus CD8 ratios and have significant effects
on both T and B cell maturation and cell death. Deltex death, enforced expression of activated Notch would
rescue these cells, resulting in an accumulation of Tis likely to inhibit E47 homodimers, which may favor
the formation or the activity of T cell±specific E47/HEB cells. This does not explain why these mice totally lack
B cells, and perhaps, in this instance, Notch is directlycomplexes. This, in turn, might participate in the regula-
tion of B versus T cell lineage decisions in common affecting cell fate through regulation of fate determining
genes. However, we argue that in many circumstances,lymphoid precursors and, later in the T cell develop-
mental pathway, TCR ab versus gd ratios as well as CD4 when examined carefully, Notch expression may indi-
rectly affect cell fate through a direct regulation of apo-expression patterns.
The data discussed above firmly place Notch signal- ptosis.
This suggestion is supported by a number of indirecting as an important arbitrator of fate determination in
the immune system. But these data do not describe how observations. Notch-1 expression represses Nur77 ac-
tivity and Nur77 is required for cell death of immatureNotch determines fate. Does Notch ªdirectº fate through
transcriptional regulation of ªfate determiningº genes? thymocytes (Jehn et al., 1999). Notch-1 expression also
rescues thymocytes from glucocorticoid-induced apo-Clearly, since Notch activity can regulate transcription,
this is quite feasible. However, we would like to suggest ptosis (Deftos et al., 1998) and this form of death also
requires a nuclear hormone receptor, GR, similar inthat an equally plausible hypothesis is that Notch deter-
mines fate through effects on apoptosis. We and others structure and function to Nur77. It is possible, therefore,
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that Notch expression represses nuclear hormone re- of relevant genes or proteins at specific developmental
stages, including mature immune system cells, to deter-ceptor activity more generally. Since many nuclear hor-
mone receptors are critical regulators of cell death, this mine the full range of physiological effects of Notch
signaling in the immune system and the precise mecha-may provide a general mechanism for influencing cell
death pathways in a wide variety of cells, including nisms by which Notch receptors exert these pleiotropic
effects.lymphoid cells. Another observation supporting our hy-
pothesis is that enforced E2A expression in immature
T cells causes apoptosis (Engel and Murre, 1999). There- Acknowledgments
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